Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retaron in LPS Induced Inflammation Model
NCT02221089Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2013
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Change in Retinal Vascular Reactivity at Day 2. Started Jan 2013; status: completed.
Beyond the preview
Go deeper on NCT02221089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02221089.